全文获取类型
收费全文 | 248篇 |
免费 | 16篇 |
国内免费 | 10篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 7篇 |
妇产科学 | 7篇 |
基础医学 | 25篇 |
口腔科学 | 3篇 |
临床医学 | 11篇 |
内科学 | 50篇 |
皮肤病学 | 1篇 |
神经病学 | 9篇 |
特种医学 | 2篇 |
外科学 | 26篇 |
综合类 | 23篇 |
预防医学 | 2篇 |
眼科学 | 3篇 |
药学 | 31篇 |
肿瘤学 | 70篇 |
出版年
2022年 | 3篇 |
2021年 | 4篇 |
2020年 | 1篇 |
2018年 | 2篇 |
2017年 | 1篇 |
2016年 | 2篇 |
2015年 | 6篇 |
2014年 | 8篇 |
2013年 | 13篇 |
2012年 | 7篇 |
2011年 | 7篇 |
2010年 | 6篇 |
2009年 | 9篇 |
2008年 | 11篇 |
2007年 | 28篇 |
2006年 | 16篇 |
2005年 | 18篇 |
2004年 | 19篇 |
2003年 | 12篇 |
2002年 | 15篇 |
2001年 | 5篇 |
2000年 | 13篇 |
1999年 | 4篇 |
1998年 | 4篇 |
1997年 | 3篇 |
1996年 | 5篇 |
1995年 | 2篇 |
1994年 | 5篇 |
1993年 | 3篇 |
1992年 | 2篇 |
1991年 | 3篇 |
1990年 | 2篇 |
1989年 | 3篇 |
1988年 | 3篇 |
1987年 | 8篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1983年 | 1篇 |
1982年 | 3篇 |
1981年 | 1篇 |
1980年 | 4篇 |
1979年 | 3篇 |
1978年 | 2篇 |
1977年 | 1篇 |
1976年 | 1篇 |
1972年 | 1篇 |
1906年 | 1篇 |
排序方式: 共有274条查询结果,搜索用时 31 毫秒
1.
Vif is dispensable for simian immunodeficiency virus (SIV) replication in some cells, termed permissive (i.e., CEM-SS), but not in others, termed non-permissive (i.e., H9, CEMx174, and peripheral blood lymphocytes). Non-permissive cells express the RNA editing enzyme, APOBEC3G. To determine whether vif mRNA could be alternatively spliced, a mutation altering the putative vif splice acceptor site (SA1) was introduced into SIV(mac239) (SIV(Deltavif-SA)). Despite three consensus splice acceptor sites nearby SA1, SIV(Deltavif-SA) did not efficiently generate alternatively spliced vif mRNA. SIV(Deltavif-SA) was growth attenuated in CEMx174 and H9 cells but not in CEM-SS cells. Following SIV(Deltavif-SA), but not SIV(mac239), infection in either H9 or CEMx174 cells viral cDNA contained numerous G to A mutations; no such differences were observed in CEM-SS cells. This pattern is consistent with mutations generated by APOBEC3G in the absence of Vif. Therefore, efficient splicing of SIV vif mRNA is tightly controlled and requires the SA1 site. 相似文献
2.
Corban-Wilhelm H Becker G Bauder-Wüst U Greulich D Debus J 《Clinical and experimental medicine》2003,3(3):150-156
The efficacy of single and combination suicide gene therapy was evaluated using a Herpes simplex virus thymidine kinase/ganciclovir system and Escherichia coli cytosine deaminase/5-fluorocytosine system on the rat prostate tumor cell line R3327 AT-1. The wild-type R3327 AT-1 cell line was transfected with a bifunctional fusion gene CDglyTK, which had the advantage that the resulting R3327 AT-1/CDglyTK cell line has the same amount of cytosine deaminase and thymidine kinase molecules. The percentage of viable R3327 AT-1/CDglyTK cells after 96 h incubation with 0.1 micro g/ml ganciclovir or 10 micro g/ml 5-fluorocytosine were 85% and 52% of controls, respectively. The cell viability when both suicide genes systems were activated was 43%. For in vivo analysis, Copenhagen rats were injected subcutaneously with R3327 AT-1 or R3327 AT-1/CDglyTK cells and treated with 30 mg/kg ganciclovir, 500 mg/kg 5-fluorocytosine, or both prodrugs together. A survival of 83% with the thymidine kinase/ganciclovir and 57% with the CD/5-FC could be observed. Only co-administration of thymidine kinase- and cytosine deaminase-specific prodrugs resulted in a 100% recurrence-free survival of the Copenhagen rats with a Dunning R3327 AT-1/CDglyTK prostate tumor and showed an additive cytotoxic effect. Calculation of the degree of activation and the potential of activation can be used to predict the success of a suicide gene therapy. In our case, the cytosine deaminase/5-fluorocytosine system had a low degree of activation (value 40), which is also found in the low response to 5- fluorocytosine in vivo (57% tumor free). 相似文献
3.
目的 :探讨大剂量阿糖胞苷 ( HDAC)治疗儿童急性白血病的效果和不良反应。 方法 :应用 HDAC治疗 3例急性髓细胞白血病 (每次 2 .0 g/m2 ,每 12 h1次 ,共 6次为一个疗程 )和 4例高危型急性淋巴细胞白血病 (每次1.0 g/m2 ,每 12 h1次 ,共 8次为一个疗程 )共 16个疗程 ,九个疗程在 HDAC结束后使用惠尔血 ( 2~ 3μg/kg)皮下注射 ,连续 10~ 14天。 结果 :6例按计划完成 HDAC治疗 ,并继续用常规方案治疗者 ,在 2 0~ 42个月的随访期内无病生存 ,1例 AL L- L3型在一个疗程 HDAC后出现中枢神经系统白血病复发 ,骨髓仍缓解 ,7个月后放弃治疗 .骨髓严重抑制和感染是最主要的不良反应 ,加用惠尔血可使粒细胞缺乏的持续时间缩短 ,感染发生率降低。 结论 :以 HDAC为主的联合化疗方案可安全地用于儿童急性白血病的强化治疗 ,对降低复发、提高无病生存率有积极意义 相似文献
4.
以苯胺为原料经溴代、脱氨和甲氧基化反应制备1,3,5—三甲氧基苯。经改进各步收率有较大的提高总收率为63.2%。 相似文献
5.
目的 了解自杀基因胞嘧啶脱氨酶基因 (cytosinedeaminase ,CD)及其前药 5 氟胞嘧啶 (5 fluorucytosine,5 FC)和bcl Xs基因转移联合作用对卵巢癌细胞株生长的影响。方法 以复制缺陷型腺病毒为载体将CD基因和bcl Xs基因体外转染大鼠卵巢癌细胞株NUTU 19细胞 ,加入含 5 FC的培养基。MTT法检测培养细胞吸光度值 ,计算细胞存活率。结果 单一bcl Xs基因转移及单一CD /5 FC系统作用对NUTU 19细胞的生长抑制作用均随病毒滴度的增加而增大 ;将两者联合作用于NU TU 19细胞 ,其生长抑制率比两者单独使用时的生长抑制率之和更高 ,表现为协同效应 (P <0 .0 0 0 1)。结论 CD /5 FC系统与bcl Xs基因转移联合使用对NUTU 19细胞的生长抑制具有协同作用。 相似文献
6.
In order to determine whether the growth of ras oncogene-transformed cells and nontransformed cells was inhibited differently by the chemotherapuetic drug cytosine arabinoside
(Ara-C) their growth was analyzed by a novel colony-based assay that is sensitive and appropriate for heterogeneous cell populations.
Colonies of nontransformed NIH3T3 cells, or ras onco- gene-transformed NIH(ras) cells, were grown in the absence of drug and then divided into subclones. Subclones were allowed to continue to grow in
the absence or presence of drug. Growth inhibition was determined by comparing the growth of drug-treated subclones with the
growth of related untreated subclones. Colonies of nontransformed cells grown in the absence of the drug displayed a large
variation in growth, and when grown in the presence of the drug displayed a large variation in growth inhibition. Colonies
of transformed cells also displayed a large variation in the absence and presence of the drug. For each cell line, related
subclones were more similar to each other than to unrelated subclones, implying inheritance of growth rates and drug response.
For NIH3T3 cells, the growth of subclones in the presence of drug was highly correlated with the growth of related subclones
in the absence of drug. However, for NIH3T3(ras) cells the growth of subclones in the presence of drug was not correlated with the growth of related subclones in the absence
of drug. Therefore, ras oncogene-transformed and nontransformed cell populations differ in their response to Ara-C.
Received: 3 November 1995/Accepted: 30 July 1996 相似文献
7.
胞嘧啶脱氨酸基因治疗人胰腺癌的实验研究 总被引:6,自引:2,他引:4
探讨腺病毒介导的大肠杆菌胞嘧啶脱氨酶基因用于人胰腺癌基因疗法的可行性。方法将含癌胚抗原启动子的重组腺病毒感染人胰腺癌SW1990细胞和Capan-2细胞以及人宫颈癌Hela细胞,用逆转录聚合酶链反应(RT-PCR)和Westernblot检测CD基因在细胞中的表达,以MTT法比较细胞对5-氟胞嘧(5-FC)的敏感性差异。建立胰腺癌裸鼠皮下移植瘤模型,观察CD基因的原位治疗效应及安全性。结果腺病毒介 相似文献
8.
Effect of Granulocyte Colony-Stimulating Factor on Chemotherapeutic Activity of Cytosine Arabinoside in Acute Leukemic Cell Lines 总被引:1,自引:0,他引:1
Recent studies have shown the presence of receptors for granulocyte colony-stimulating factor (G-CSF) on lymphoid leukemic cells. To determine the effect of G-CSF on chemotherapeutic activity of cytosine arabinoside (Ara-C) on lymphoid as well as myeloid leukemic cells, we evaluated cell counts, apoptosis, and growth inhibition in HL-60, KG-1, Molt-4, Jijoye, and CCRF-CEM cell lines after incubation with Ara-C (0.1 and 1 micromol/L) and/or 5 ng/mL G-CSE G-CSF potentiated the effect of Ara-C on 2 of 3 lymphoid leukemic cell lines (Molt-4 and Jijoye), whereas it decreased the apoptosis and the effect of Ara-C on myeloid cell lines (HL-60 and KG-1). 相似文献
9.
目的 探讨利用放射性核素153Sm体外标记胞嘧啶进行肿瘤代谢显像的可行性.方法 胞嘧啶与DTPA的偶联产物C-DTPA,经纯化后体外标记153Sm,并对得到的显像剂C-DTPA-153 Sm的质量规格进行检测:①制剂要求:检菌,热原检测;②毒理学:急性毒理测定;③特殊参数:标记率,体外稳定性;④药动学:家兔血浆药物代谢动力学;⑤药效学:体外细胞显像,荷瘤小鼠显像.结果 体外实验、动物实验显示C-DTPA-153Sm为无菌、无热原、无毒性的安全制剂,并且可以在肿瘤部位浓集.结论 153Sm标记胞嘧啶代谢显像方法对多种肿瘤有诊断价值,可以无创性的体内评价肿瘤的增生状态,具有重要的临床应用价值. 相似文献
10.
The antiretroviral activity of APOBEC3 is inhibited by the foamy virus accessory Bet protein 总被引:13,自引:0,他引:13
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)